The IDE process involves several key stages, including defining the investigational plan, obtaining Institutional Review Board (IRB) approval, preparing detailed documentation, and securing FDA authorization. Once approved, an IDE permits the legal shipment and testing of the investigational device without requiring full marketing clearance during the trial phase.

These trials are particularly vital for significant-risk and Class III devices, where patient safety is a top priority. Sponsors must demonstrate that potential benefits outweigh the risks, ensure strong scientific methodology, and maintain strict compliance with ethical and regulatory standards.

FDA IDE clinical trials play a pivotal role in advancing medical device innovation, ensuring patient protection, and accelerating the delivery of life-saving technologies to the market.